News & Events

Redefining the Treatment of Polycythemia Vera ~ 11/21/22

Congressional Support for the Lymphedema Treatment Act

Cytopenia Myelofibrosis (MF) and VONJO (pacritinib) Overview ~ 10/20/22

Educating Your Patients on IMBRUVICA Treatment for CLL/SLL: A Case-Based Approach ~ 10/12/22

ZYNLONTA: The first and only CD19-direct ADC for 3L DLBCL ~ November 11th, 2022

The Clinical Role of VITRAKVI (larotrectinib): Presentation on NTRK Gene Fusions ~ 10/5/22

Educating Your Patients on IMBRUVICA Treatment for CLL/SLL: A Case-based Approach ~ Tomorrow night!

Connecting Care Teams ~ Spotlight on a Person-Centered Tumor Board for Cancer and Mental Illness

Discussion of BRUKINSA in WM and R/R MZL - Virtual and multiple dates!

A Treatment for Patients with METex14 Skipping Metastatic NSCLC ~ 10/4/22 @ 6pm

Pyruvate Kinase Deficiency: Clinical Manifestations and a New Treatment Option ~ Virtual - 10/12/22

Educating Your Patients on IMBRUVICA Treatment for CLL/SLL A Case-Based Approach ~ Wednesday, 9/21

BLENREP in Practice: A Patient Profile-Based Interactive Discussion ~ 10/25/22

Learn more about the Treatment of Carcinoid Syndrome Diarrhea ~ 9/14/22 @ 6:00pm

Learn more about Treatment of Carcinoid Syndrome Diarrhea ~ 9/13/22 @6:30pm

Please join us for a clinical overview of VORAXAZE ~ 9/7/22 @6:30pm

DLBCL and Epcoritamab, A CD3xCD20 Bispecific ~ 8/4/22 @ 6PM

Tisotumab Vedotin: Adverse Events and Management ~ 8/2/22 @6pm

Changing the Standard of Care for Patients with RET+ mNSCLC or Advanced Thyroid Cancer ~ 9/29/22

TONIGHT @ Morton's @6pm! Don't miss it!